These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 7976208

  • 1. The induction of specific protection against Actinobacillus pleuropneumoniae infection by specific DLE.
    Snirc J, Mikula I, Pistl J.
    Acta Microbiol Hung; 1993; 40(4):325-33. PubMed ID: 7976208
    [Abstract] [Full Text] [Related]

  • 2. Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxIIA.
    Shin SJ, Bae JL, Cho YW, Lee DY, Kim DH, Yang MS, Jang YS, Yoo HS.
    FEMS Immunol Med Microbiol; 2005 Feb 01; 43(2):155-64. PubMed ID: 15681145
    [Abstract] [Full Text] [Related]

  • 3. [Construction and immunogenicity of an attenuated mutant of Actinobacillus pleuropneumoniae by insertional inactivation of apxIC].
    Xu FZ, Shi AH, Chen XL, Yang B, Wang JL.
    Wei Sheng Wu Xue Bao; 2007 Oct 01; 47(5):923-7. PubMed ID: 18062275
    [Abstract] [Full Text] [Related]

  • 4. Comparison of different doses of antigen for intradermal administration in pigs: the Actinobacillus pleuropneumoniae model.
    Bernardy J, Nechvatalova K, Krejci J, Kudlacková H, Brazdova I, Kucerova Z, Faldyna M.
    Vaccine; 2008 Nov 25; 26(50):6368-72. PubMed ID: 18824203
    [Abstract] [Full Text] [Related]

  • 5. Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae.
    Wang C, Wang Y, Shao M, Si W, Liu H, Chang Y, Peng W, Kong X, Liu S.
    Vaccine; 2009 Sep 25; 27(42):5816-21. PubMed ID: 19654060
    [Abstract] [Full Text] [Related]

  • 6. [Study of the virulence of Actinobacillus pleuropneumoniae in finishing pigs as a basis for vaccination development].
    Hennig-Pauka I, Baltes N, Jacobsen I, Stratmann-Selke J, Gerlach GF, Selbitz HJ, Waldmann KH.
    Berl Munch Tierarztl Wochenschr; 2008 Sep 25; 121(5-6):189-97. PubMed ID: 18557522
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of immunogenicity and protective efficacy of Actinobacillus pleuropneumoniae HB04C(-) mutant lacking a drug resistance marker in the pigs.
    Bei W, He Q, Zhou R, Yan L, Huang H, Chen H.
    Vet Microbiol; 2007 Nov 15; 125(1-2):120-7. PubMed ID: 17580102
    [Abstract] [Full Text] [Related]

  • 8. Protective effects of partially purified antigens of Actinobacillus pleuropneumoniae on experimentally infected mice.
    Liu JL, Chang IC, Chen CM, Weng CN.
    J Microbiol Immunol Infect; 1999 Dec 15; 32(4):223-32. PubMed ID: 10650486
    [Abstract] [Full Text] [Related]

  • 9. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.
    Maas A, Meens J, Baltes N, Hennig-Pauka I, Gerlach GF.
    Vaccine; 2006 Nov 30; 24(49-50):7226-37. PubMed ID: 17027123
    [Abstract] [Full Text] [Related]

  • 10. Selection of serotype-specific vaccine candidate genes in Actinobacillus pleuropneumoniae and heterologous immunization with Propionibacterium acnes.
    Lei L, Sun C, Lu S, Feng X, Wang J, Han W.
    Vaccine; 2008 Nov 18; 26(49):6274-80. PubMed ID: 18835316
    [Abstract] [Full Text] [Related]

  • 11. Potential use an Actinobacillus pleuropneumoniae double mutant strain DeltaapxIICDeltaapxIVA as live vaccine that allows serological differentiation between vaccinated and infected animals.
    Liu J, Chen X, Lin L, Tan C, Chen Y, Guo Y, Jin M, Guo A, Bei W, Chen H.
    Vaccine; 2007 Nov 01; 25(44):7696-705. PubMed ID: 17767980
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity and protective efficacy of ApxIA and ApxIIA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model.
    Chiang CH, Huang WF, Huang LP, Lin SF, Yang WJ.
    Vaccine; 2009 Jul 23; 27(34):4565-70. PubMed ID: 19520199
    [Abstract] [Full Text] [Related]

  • 13. Characterization and immunogenicity of an apxIA mutant of Actinobacillus pleuropneumoniae.
    Xu F, Chen X, Shi A, Yang B, Wang J, Li Y, Guo X, Blackall PJ, Yang H.
    Vet Microbiol; 2006 Dec 20; 118(3-4):230-9. PubMed ID: 16930871
    [Abstract] [Full Text] [Related]

  • 14. Effect of subclinical infection with Actinobacillus pleuropneumoniae in commingled feeder swine.
    Rohrbach BW, Hall RF, Hitchcock JP.
    J Am Vet Med Assoc; 1993 Apr 01; 202(7):1095-8. PubMed ID: 8473222
    [Abstract] [Full Text] [Related]

  • 15. Construction and immunogencity of a DeltaapxIC/DeltaapxIIC double mutant of Actinobacillus pleuropneumoniae serovar 1.
    Lin L, Bei W, Sha Y, Liu J, Guo Y, Liu W, Tu S, He Q, Chen H.
    FEMS Microbiol Lett; 2007 Sep 01; 274(1):55-62. PubMed ID: 17608699
    [Abstract] [Full Text] [Related]

  • 16. Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state.
    Hensel A, Huter V, Katinger A, Raza P, Strnistschie C, Roesler U, Brand E, Lubitz W.
    Vaccine; 2000 Jul 01; 18(26):2945-55. PubMed ID: 10825595
    [Abstract] [Full Text] [Related]

  • 17. Risk assessment of transmission of capsule-deficient, recombinant Actinobacillus pleuropneumoniae.
    Inzana TJ, Glindemann G, Fenwick B, Longstreth J, Ward D.
    Vet Microbiol; 2004 Nov 30; 104(1-2):63-71. PubMed ID: 15530740
    [Abstract] [Full Text] [Related]

  • 18. AasP autotransporter protein of Actinobacillus pleuropneumoniae does not protect pigs against homologous challenge.
    Oldfield NJ, Worrall KE, Rycroft AN, Ali T, Wooldridge KG, Ala'Aldeen DA.
    Vaccine; 2009 Aug 20; 27(38):5278-83. PubMed ID: 19563888
    [Abstract] [Full Text] [Related]

  • 19. Actinobacillus pleuropneumoniae vaccines: from bacterins to new insights into vaccination strategies.
    Ramjeet M, Deslandes V, Gouré J, Jacques M.
    Anim Health Res Rev; 2008 Jun 20; 9(1):25-45. PubMed ID: 18346296
    [Abstract] [Full Text] [Related]

  • 20. Effect of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with a vaccine containing Apx toxins and transferrin-binding proteins.
    Van Overbeke I, Chiers K, Ducatelle R, Haesebrouck F.
    J Vet Med B Infect Dis Vet Public Health; 2001 Feb 20; 48(1):15-20. PubMed ID: 11254095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.